1075 Proteogenomic characterization of HBV-related hepatocellular carcinoma (HCC) using paired tumor and adjacent liver tissues identifies three subgroups with distinct features in metabolic reprogramming, microenvironment dysregulation, cell proliferation, and potential therapeutics.
https://www.cell.com/cell/fulltext/S0092-8674(19)31003-7
1074 PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity.
https://www.nature.com/articles/s41590-019-0480-4
1073 Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
https://stm.sciencemag.org/content/11/513/eaay2574
1072 Analyses of transcriptomes from patients with acute myeloid leukaemia identified frequently co-occurring mutations of IDH2 and SRSF2, which functional analyses showed to have distinct and coordinated leukaemogenic effects on the epigenome and RNA splicing.
https://www.nature.com/articles/s41586-019-1618-0
1071 Inducing and exploiting vulnerabilities for the treatment of liver cancer.
https://www.nature.com/articles/s41586-019-1607-3
1070 Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.
https://www.pnas.org/content/116/41/20679
1069 α-Ketoglutarate links p53 to cell fate during tumour suppression.
https://www.nature.com/articles/s41586-019-1577-5
1068 E-cadherin is required for metastasis in multiple models of breast cancer.
https://www.nature.com/articles/s41586-019-1526-3
1067 Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.
https://stm.sciencemag.org/content/11/509/eaaw8513
1066 Collagen-binding ability improves serum albumin as an anti-cancer drug carrier, resulting in enhanced therapeutic efficacy.
https://advances.sciencemag.org/content/5/8/eaaw6081
1065 A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling.
https://advances.sciencemag.org/content/5/8/eaav6789
1064 A cell-penetrating fluorescent marker is used to label cells in the metastatic tumour microenvironment, revealing a variety of cell types including parenchymal cells with lung stem-cell characteristics.
https://www.nature.com/articles/s41586-019-1487-6
1063 Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(19)30188-3
1062 Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
https://onlinelibrary.wiley.com/doi/10.1002/adma.201803953
1061 Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
https://onlinelibrary.wiley.com/doi/10.1002/adma.201803322
1060 Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
https://www.cell.com/cell/fulltext/S0092-8674(19)30773-1
1059 Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.
https://www.nature.com/articles/s41586-019-1450-6
1058 Repurposing dasatinib for diffuse large B cell lymphoma.
https://www.pnas.org/content/116/34/16981
1057 Proper dosing and timing of EGFR TKI can trigger antitumor T cell responses and potentiate anti–PD-L1 immunotherapy.
https://immunology.sciencemag.org/content/4/38/eaav6473
1056 Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling.
https://www.nature.com/articles/s41586-019-1426-6
|
